Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

BILD-1351 for HSV infection

April 5, 1996

BMS discloses novel cephalosporins

April 5, 1996

MBI-10 antibiotics effective against resistant staphylococci

April 5, 1996

Glaxo Wellcome, Quidel collaborate on flu management

March 15, 1996

Lidakol clinical trial update

March 15, 1996

Antiviral drugs from Glaxo Wellcome

March 15, 1996

Human lactoferrin produced in transgenic animals

March 15, 1996

UR-9751 dropped from development

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 17, 2025.
Blenrep misstep? ODAC cites tox, GSK dosing neglect in MM
BioWorld
The rough ride presaged by briefing documents came to pass for GSK plc with the drug first approved by the U.S. FDA as Blenrep (belantamab mafodotin, bel-maf), as...
Atai Therapeutics discovers new 5-HT2A receptor partial agonists
BioWorld Science
Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...
PHD inhibitors reported in Akebia Therapeutics patent
BioWorld Science
Akebia Therapeutics Inc. has identified new derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate acting as prolyl 4-hydroxylase (PHD) inhibitors.